Skip to Main Content

Sugammadex and Decreased Time to Extubation


Diseases of the Cardiovascular System

Phase Pilot

What is the purpose of this trial?

The purpose of this study is to demonstrate faster time to extubation after arrival in the cardiothoracic intensive care unit (ICU) in patients undergoing isolated coronary artery bypass grafting (CABG) who receive Sugammadex as compared to placebo.

  • Trial with
    Merck Sharp & Dohme
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC